Alexandre Marchand

1.7k total citations
60 papers, 1.4k citations indexed

About

Alexandre Marchand is a scholar working on Molecular Biology, Hematology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Alexandre Marchand has authored 60 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 19 papers in Hematology and 15 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Alexandre Marchand's work include Erythropoietin and Anemia Treatment (15 papers), Biosimilars and Bioanalytical Methods (10 papers) and Hormonal and reproductive studies (9 papers). Alexandre Marchand is often cited by papers focused on Erythropoietin and Anemia Treatment (15 papers), Biosimilars and Bioanalytical Methods (10 papers) and Hormonal and reproductive studies (9 papers). Alexandre Marchand collaborates with scholars based in France, United States and Switzerland. Alexandre Marchand's co-authors include Michèle Garlatti, Robert Barouki, Armelle Baeza‐Squiban, Francelyne Marano, Augustin Baulig, Anne‐Marie Lompré, Véronique Bonvallot, Laurent Martin, Fabrice Atassi and Magnus Ericsson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Alexandre Marchand

56 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexandre Marchand France 20 552 319 238 188 180 60 1.4k
Robert Schoonhoven United States 25 908 1.6× 318 1.0× 372 1.6× 259 1.4× 209 1.2× 37 3.0k
Noriko Nishimura Japan 30 1.2k 2.1× 941 2.9× 245 1.0× 263 1.4× 162 0.9× 130 3.0k
Jing Shao China 19 287 0.5× 232 0.7× 118 0.5× 108 0.6× 75 0.4× 46 1.0k
Liping Han China 25 718 1.3× 243 0.8× 184 0.8× 131 0.7× 89 0.5× 75 1.7k
Wakako Takabe Japan 24 958 1.7× 158 0.5× 284 1.2× 276 1.5× 53 0.3× 64 1.8k
Catherine A. Lemarié Canada 23 402 0.7× 136 0.4× 161 0.7× 352 1.9× 254 1.4× 52 1.6k
Xi Huang United States 24 622 1.1× 177 0.6× 354 1.5× 297 1.6× 55 0.3× 77 2.1k
Michael W. Lamé United States 30 1.0k 1.8× 286 0.9× 167 0.7× 120 0.6× 68 0.4× 70 2.1k
Srinivas D Sithu United States 19 368 0.7× 174 0.5× 182 0.8× 207 1.1× 56 0.3× 24 1.2k
Stephen J. Pollock United States 22 529 1.0× 126 0.4× 224 0.9× 378 2.0× 99 0.6× 39 1.7k

Countries citing papers authored by Alexandre Marchand

Since Specialization
Citations

This map shows the geographic impact of Alexandre Marchand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandre Marchand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandre Marchand more than expected).

Fields of papers citing papers by Alexandre Marchand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexandre Marchand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandre Marchand. The network helps show where Alexandre Marchand may publish in the future.

Co-authorship network of co-authors of Alexandre Marchand

This figure shows the co-authorship network connecting the top 25 collaborators of Alexandre Marchand. A scholar is included among the top collaborators of Alexandre Marchand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexandre Marchand. Alexandre Marchand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Figueiredo, Miguel de, Alexandre Marchand, Damien Rhumorbarbe, et al.. (2025). Evaluating the Early Operational Performance of the Endocrine Module in the Athlete Biological Passport. Drug Testing and Analysis. 17(10). 1865–1876.
2.
Sakellariou, P., Katja Walpurgis, Andreas Thomas, et al.. (2025). Combined detection of inhibitors of the activin receptor signaling pathways (IASPs) by means of LC-HRMS/MS for human doping control. Scientific Reports. 15(1). 19887–19887.
3.
Collomp, Katia, Caroline Teulier, Carole Castanier, et al.. (2025). Impact of Menstrual Cycle and Oral Contraceptives on Haematological and Inflammatory Biomarkers in Highly Trained Female Athletes. Drug Testing and Analysis. 17(9). 1580–1587.
4.
Marchand, Alexandre & Magnus Ericsson. (2024). Homologous blood transfusion and doping: Where are we now?. Drug Testing and Analysis. 16(12). 1479–1486. 2 indexed citations
5.
Loup, Benoît, François André, Nicolas Leuenberger, et al.. (2024). New Transcriptomic Biomarkers for Detection of the Recombinant Human Erythropoietin (rHuEPO) MirCERA in Horses. Drug Testing and Analysis. 17(7). 1078–1087. 2 indexed citations
6.
Marchand, Alexandre, et al.. (2023). Evaluation of the detection of the homologous transfusion of a red blood cell concentrate in vivo for antidoping. Drug Testing and Analysis. 15(11-12). 1417–1429. 7 indexed citations
7.
8.
Narduzzi, Luca, Corinne Buisson, Marie‐Line Morvan, et al.. (2021). Coupling Complete Blood Count and Steroidomics to Track Low Doses Administration of Recombinant Growth Hormone: An Anti-Doping Perspective. Frontiers in Molecular Biosciences. 8. 683675–683675. 10 indexed citations
9.
Narduzzi, Luca, Gaud Dervilly, Alexandre Marchand, et al.. (2020). Applying metabolomics to detect growth hormone administration in athletes: Proof of concept. Drug Testing and Analysis. 12(7). 887–899. 14 indexed citations
10.
M’Baya-Moutoula, Eléonore, Alexandre Marchand, Isabelle Six, et al.. (2019). Inhibition of miR-223 Expression Using a Sponge Strategy Decreases Restenosis in Rat Injured Carotids. Current Vascular Pharmacology. 18(5). 507–516. 8 indexed citations
11.
Buisson, Corinne, et al.. (2016). Detection by LC–MS/MS of HIF stabilizer FG-4592 used as a new doping agent: Investigation on a positive case. Journal of Pharmaceutical and Biomedical Analysis. 121. 181–187. 43 indexed citations
12.
Hadri, Lahouaria, Zela Keuylian, Nathalie Mougenot, et al.. (2013). Efficient transduction of vascular smooth muscle cells with a translational AAV2.5 vector: a new perspective for in-stent restenosis gene therapy. Gene Therapy. 20(9). 901–912. 25 indexed citations
13.
Atassi, Fabrice, Rajender K. Motiani, Nathalie Mougenot, et al.. (2013). miR-424/322 regulates vascular smooth muscle cell phenotype and neointimal formation in the rat. Cardiovascular Research. 98(3). 458–468. 90 indexed citations
14.
Lipskaia, Larissa, Alexandre Marchand, Lahouaria Hadri, et al.. (2012). A calcium-sensitive promoter construct for gene therapy. Gene Therapy. 20(3). 248–254. 15 indexed citations
15.
Bui, Linh Chi, Stéphane Pierre, Aline Chevallier, et al.. (2010). 2,3,7,8-Tetrachlorodibenzo-p-Dioxin Counteracts the p53 Response to a Genotoxicant by Upregulating Expression of the Metastasis Marker AGR2 in the Hepatocarcinoma Cell Line HepG2. Toxicological Sciences. 115(2). 501–512. 27 indexed citations
16.
Marchand, Alexandre, Fabrice Atassi, Pascal Leprince, et al.. (2010). The Wnt/beta‐catenin pathway is activated during advanced arterial aging in humans. Aging Cell. 10(2). 220–232. 103 indexed citations
17.
Marchand, Alexandre, Anne-Marie Lund Winther, Peter J. Holm, et al.. (2008). Crystal Structure of D351A and P312A Mutant Forms of the Mammalian Sarcoplasmic Reticulum Ca2+-ATPase Reveals Key Events in Phosphorylation and Ca2+ Release. Journal of Biological Chemistry. 283(21). 14867–14882. 29 indexed citations
18.
Blanc, Étienne, Alexandre Marchand, Pierre Fafournoux, et al.. (2007). Stabilization of IGFBP-1 mRNA by ethanol in hepatoma cells involves the JNK pathway. Journal of Hepatology. 47(5). 691–698. 12 indexed citations
19.
Marchand, Alexandre, et al.. (2004). 2,3,7,8-Tetrachlorodibenzo-p-dioxin Induces Insulin-Like Growth Factor Binding Protein-1 Gene Expression and Counteracts the Negative Effect of Insulin. Molecular Pharmacology. 67(2). 444–452. 45 indexed citations
20.
Arkel, Yale S., et al.. (1997). A Highly Specific Functional Test for Factor V Leiden: A Modified Tissue Factor Assay for Activated Protein C Resistance. Pathophysiology of Haemostasis and Thrombosis. 27(6). 290–304. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert Schoonhoven Breakdown of academic impact, for papers by Noriko Nishimura Breakdown of academic impact, for papers by Jing Shao Breakdown of academic impact, for papers by Liping Han Breakdown of academic impact, for papers by Wakako Takabe Breakdown of academic impact, for papers by Catherine A. Lemarié Breakdown of academic impact, for papers by Xi Huang Breakdown of academic impact, for papers by Michael W. Lamé Breakdown of academic impact, for papers by Srinivas D Sithu Breakdown of academic impact, for papers by Stephen J. Pollock
Rankless by CCL
2026